Advertisement
Advertisement

JAGX

JAGX logo

Jaguar Health, Inc.

2.68
USD
Sponsored
+0.12
+4.69%
Jun 24, 16:00 UTC -4
Closed
exchange

Pre-Market

2.63

-0.05
-1.68%

JAGX Earnings Reports

Positive Surprise Ratio

JAGX beat 13 of 31 last estimates.

42%

Next Report

Date of Next Report
Aug 12, 2026
Estimate for Q2 26 (Revenue/ EPS)
$4.33M
/
-$1.51
Implied change from Q1 26 (Revenue/ EPS)
-78.64%
/
-88.90%
Implied change from Q2 25 (Revenue/ EPS)
+47.48%
/
-99.58%

Jaguar Health, Inc. earnings per share and revenue

On May 20, 2026, JAGX reported earnings of -13.60 USD per share (EPS) for Q1 26, missing the estimate of -2.08 USD, resulting in a -553.59% surprise. Revenue reached 20.27 million, compared to an expected 3.74 million, with a 441.78% difference. The market reacted with a -5.45% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 3 analysts forecast an EPS of -1.51 USD, with revenue projected to reach 4.33 million USD, implying an decrease of -88.90% EPS, and decrease of -78.64% in Revenue from the last quarter.
FAQ
For Q1 2026, Jaguar Health, Inc. reported EPS of -$13.60, missing estimates by -553.59%, and revenue of $20.27M, 441.78% above expectations.
The stock price moved down -5.45%, changed from $3.67 before the earnings release to $3.47 the day after.
The next earning report is scheduled for Aug 12, 2026.
Based on 3 analysts, Jaguar Health, Inc. is expected to report EPS of -$1.51 and revenue of $4.33M for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement